KRRO Korro Bio Inc.

  1. Stocks
  2. Healthcare
  3. NASDAQ: KRRO

Price (delayed)

$58.24

Market cap

$467.2M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$53.08

Enterprise value

$330.69M

frequency therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. through the controlled activation of progenitor cells, frequency enables disease modification without the ...

Highlights
KRRO's quick ratio has surged by 91% since the previous quarter and by 36% year-on-year
KRRO's EPS has soared by 77% YoY and by 73% QoQ
KRRO's net income has dropped by 127% since the previous quarter and by 40% year-on-year
Sector: Healthcare
Industry: Biotechnology
Website: http://frequencytx.com
Peers: OMER OMGA

Key stats

What are the main financial stats of KRRO
Market
Shares outstanding
8.02M
Market cap
$467.2M
Enterprise value
$330.69M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.74
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$81.15M
EBITDA
-$73.91M
Free cash flow
-$75.12M
Per share
EPS
-$53.08
Free cash flow per share
-$49.12
Book value per share
$21.24
Revenue per share
$0
TBVPS
$144.94
Balance sheet
Total assets
$221.66M
Total liabilities
$51.75M
Debt
$33.21M
Equity
$169.91M
Working capital
$153.25M
Liquidity
Debt to equity
0.2
Current ratio
8.87
Quick ratio
8.71
Net debt/EBITDA
1.85
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-72.3%
Return on equity
-106.3%
Return on invested capital
-167.1%
Return on capital employed
-40.1%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

KRRO stock price

How has the Korro Bio stock price performed over time
Intraday
0.03%
1 week
-7.45%
1 month
-25.3%
1 year
15,348.28%
YTD
21.51%
QTD
-35.29%

Financial performance

How have Korro Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$84.53M
Net income
-$81.17M
Gross margin
N/A
Net margin
N/A
KRRO's net income has dropped by 127% since the previous quarter and by 40% year-on-year
KRRO's operating income has dropped by 116% since the previous quarter and by 43% year-on-year

Growth

What is Korro Bio's growth rate over time

Valuation

What is Korro Bio stock price valuation
P/E
N/A
P/B
2.74
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
KRRO's EPS has soared by 77% YoY and by 73% QoQ
The stock's price to book (P/B) is 37% more than its 5-year quarterly average of 2.0

Efficiency

How efficient is Korro Bio business performance
KRRO's ROIC has plunged by 83% from the previous quarter
The return on equity has surged by 73% since the previous quarter and by 12% year-on-year
KRRO's return on assets has dropped by 63% year-on-year and by 52% since the previous quarter

Dividends

What is KRRO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for KRRO.

Financial health

How did Korro Bio financials performed over time
The current ratio has soared by 101% from the previous quarter and by 35% YoY
KRRO's quick ratio has surged by 91% since the previous quarter and by 36% year-on-year
Korro Bio's debt is 80% less than its equity

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.